(ADPnews) - Jan 24, 2011 - Several brokers have upgraded their share price targets on Danish industrial enzymes maker Novozymes A/S (CPH:NZYM B) after the company presented on Friday better-than-expected sales and profit for 2010.
Deutsche Bank and SEB Enskilda have lifted their targets on Novozymes to DKK 900 from DKK 850 and DKK 885, respectively. Both brokers have maintained their "buy" stance.
JP Morgan has revised its target to DKK 760 from DKK 700 and has kept its "neutral" recommendation.
Novozymes' target has also been upgraded by Jefferies to DKK 860 from DKK 810, by S&P Equity Research to DKK 800 from DKK 750 and by Danske Markets to DKK …
No comments:
Post a Comment